In the final results of a major international clinical trial, women with hormone receptor-negative breast cancer who received a combination of standard chemotherapy and hormone treatment were more likely to become pregnant and enjoyed a better five-year survival rate than patients who received chemotherapy alone.
Research presented at a meeting of the Radiological Society of North America (RSNA) adds to existing evidence that women age 75 or older benefit from continued mammography screening, expanding the debate about whether the age recommendations for these screenings should change.
More Aggressive Combination Therapy Offers Survival Advantage for High-Risk Prostate Cancer Patients
Men with locally or regionally advanced prostate cancer who receive radical prostatectomy followed by radiation therapy live longer than those who receive radiation therapy plus androgen deprivation therapy (ADT), according to a recent study.
Avoiding a Late Supper Associated with Reduced Prostate Cancer Risk
Eating supper before 9 p.m. or waiting a minimum of two hours after eating before going to bed is linked to a 20 percent reduction in prostate cancer risk, according to research in the International Journal of Cancer.